1/9
04:32 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Jan 08
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Jan 08
1/9
04:31 pm
glue
Form 424B5 Monte Rosa Therapeutics,
Medium
Report
Form 424B5 Monte Rosa Therapeutics,
1/9
04:19 pm
glue
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
Medium
Report
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
1/9
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 07 Filed by: Warmuth Markus
Low
Report
Form 4 Monte Rosa Therapeutics, For: Jan 07 Filed by: Warmuth Markus
1/8
02:19 pm
glue
Form 144/A Monte Rosa Therapeutics, Filed by: Warmuth Markus
Low
Report
Form 144/A Monte Rosa Therapeutics, Filed by: Warmuth Markus
1/7
04:58 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
1/7
04:18 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Jan 07
High
Report
Form 8-K Monte Rosa Therapeutics, For: Jan 07
1/7
04:07 pm
glue
Form 424B5 Monte Rosa Therapeutics,
High
Report
Form 424B5 Monte Rosa Therapeutics,
1/7
07:07 am
glue
Form 8-K Monte Rosa Therapeutics, For: Jan 07
High
Report
Form 8-K Monte Rosa Therapeutics, For: Jan 07
1/5
04:06 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Nickson Philip
High
Report
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Nickson Philip
1/5
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 05 Filed by: Dunn Edmund
High
Report
Form 4 Monte Rosa Therapeutics, For: Jan 05 Filed by: Dunn Edmund
1/5
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Champoux Jennifer
High
Report
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Champoux Jennifer
1/5
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Warmuth Markus
High
Report
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Warmuth Markus
1/5
04:04 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Janku Filip
High
Report
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Janku Filip
1/5
04:04 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Townson Sharon
High
Report
Form 4 Monte Rosa Therapeutics, For: Jan 02 Filed by: Townson Sharon
1/5
04:02 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
High
Report
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
12/16
07:31 am
glue
Form 8-K Monte Rosa Therapeutics, For: Dec 16
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Dec 16
11/14
12:20 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/14
09:08 am
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Avoro Capital Advisors LLC
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Avoro Capital Advisors LLC
11/12
04:13 pm
glue
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
Low
Report
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
11/6
07:05 am
glue
Form 10-Q Monte Rosa Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Monte Rosa Therapeutics, For: Sep 30
11/6
07:03 am
glue
Form 8-K Monte Rosa Therapeutics, For: Nov 06
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Nov 06
10/31
11:04 am
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: VANGUARD GROUP INC
10/17
04:29 pm
glue
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: TCG Crossover GP II, LLC
Low
Report
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: TCG Crossover GP II, LLC